These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7073946)

  • 1. Liposomally trapped AraCTP to overcome AraC resistance in a murine lymphoma in vitro.
    Richardson VJ; Curt GA; Ryman BE
    Br J Cancer; 1982 Apr; 45(4):559-64. PubMed ID: 7073946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of liposomally trapped antitumour drugs on a drug-resistant mouse lymphoma in vivo.
    Richardson VJ; Ryman BE
    Br J Cancer; 1982 Apr; 45(4):552-8. PubMed ID: 7073945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cytosine arabinoside triphosphate on the incorporation of 3H-thymidine in mitochondria isolated from HeLa cells.
    Mattoccia LP; Sorrentino R
    J Cell Physiol; 1979 Oct; 101(1):17-23. PubMed ID: 541351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of gemcitabine and araC on in vitro DNA synthesis mediated by the human breast cell DNA synthesome.
    Jiang HY; Hickey RJ; Abdel-Aziz W; Malkas LH
    Cancer Chemother Pharmacol; 2000; 45(4):320-8. PubMed ID: 10755321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of in vitro assays for detecting subpopulations of P388 leukemic cells resistant to AraC.
    Raza A; Kuliczkowski K; Weidong G; Preisler HD
    Med Oncol Tumor Pharmacother; 1984; 1(3):163-8. PubMed ID: 6544897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long intracellular retention of 4'-thio-arabinofuranosylcytosine 5'-triphosphate as a critical factor for the anti-solid tumor activity of 4'-thio-arabinofuranosylcytosine.
    Someya H; Waud WR; Parker WB
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):772-80. PubMed ID: 16180016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma.
    Wiley JS; Taupin J; Jamieson GP; Snook M; Sawyer WH; Finch LR
    J Clin Invest; 1985 Feb; 75(2):632-42. PubMed ID: 3871794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of DNA polymerase inhibitors on repair of gamma ray-induced DNA damage in proliferating (intact versus permeable) human fibroblasts: evidence for differences in the modes of action of aphidicolin and 1-beta-D-arabinofuranosylcytosine.
    Mirzayans R; Enns L; Cubitt S; Karimian K; Radatus B; Paterson MC
    Biochim Biophys Acta; 1994 Oct; 1227(1-2):92-100. PubMed ID: 7918688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclopentenyl cytosine increases the phosphorylation and incorporation into DNA of 1-beta-D-arabinofuranosyl cytosine in a human T-lymphoblastic cell line.
    Verschuur AC; Van Gennip AH; Leen R; Voûte PA; Brinkman J; Van Kuilenburg AB
    Int J Cancer; 2002 Apr; 98(4):616-23. PubMed ID: 11920624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the intracellular pharmacokinetics of cytosine arabinoside (AraC) between circulating leukemic blasts and normal mononuclear blood cells.
    Hiddemann W; Schleyer E; Unterhalt M; Zühlsdorf M; Rolf C; Reuter C; Kewer U; Uhrmeister C; Wörmann B; Büchner T
    Leukemia; 1992 Dec; 6(12):1273-80. PubMed ID: 1453772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells.
    Bouffard DY; Jolivet J; Leblond L; Hamelin B; Ouellet F; Barbeau S; Richard A; Gourdeau H
    Cancer Chemother Pharmacol; 2003 Dec; 52(6):497-506. PubMed ID: 12955470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleoside transport and cytosine arabinoside (araC) metabolism in human T lymphoblasts resistant to araC, thymidine and 6-methylmercaptopurine riboside.
    Young I; Young GJ; Wiley JS; van der Weyden MB
    Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1077-82. PubMed ID: 3877635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saturation of intracellular cytosine arabinoside triphosphate accumulation in human leukemic blast cells.
    Jamieson GP; Snook MB; Wiley JS
    Leuk Res; 1990; 14(5):475-9. PubMed ID: 2345470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing therapy for acute myeloid leukemia based on differences in intracellular metabolism of cytosine arabinoside between leukemic blasts and normal mononuclear blood cells.
    Hiddemann W; Schleyer E; Unterhalt M; Kern W; Büchner T
    Ther Drug Monit; 1996 Aug; 18(4):341-9. PubMed ID: 8857548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma cells.
    Grem JL; Geoffroy F; Politi PM; Cuddy DP; Ross DD; Nguyen D; Steinberg SM; Allegra CJ
    Mol Pharmacol; 1995 Aug; 48(2):305-15. PubMed ID: 7651364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of intracellular metabolism of cytosine arabinoside in acute myeloid leukemia by granulocyte-macrophage colony-stimulating factor.
    Reuter C; Auf der Landwehr U; Schleyer E; Zühlsdorf M; Ameling C; Rolf C; Wörmann B; Büchner T; Hiddemann W
    Leukemia; 1994 Feb; 8(2):217-25. PubMed ID: 8309245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.
    Riva CM; Rustum YM
    Cancer Res; 1985 Dec; 45(12 Pt 1):6244-9. PubMed ID: 2998596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposome-cell interactions. A study of the interactions of liposomes containing entrapped anti-cancer drugs with the EMT6, S49 and AE1 (transport-deficient) cell lines.
    Allen TM; McAllister L; Mausolf S; Gyorffy E
    Biochim Biophys Acta; 1981 May; 643(2):346-62. PubMed ID: 7225387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inability of liposome encapsulated 1-beta-D-arabinofuranosylcytosine nucleotides to overcome drug resistance in L1210 cells.
    Rustum YM; Mayhew E; Szoka F; Campbell J
    Eur J Cancer Clin Oncol; 1981 Jul; 17(7):809-17. PubMed ID: 7199474
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship between leukemic cell retention of cytosine arabinoside triphosphate and the duration of remission in patients with acute non-lymphocytic leukemia.
    Preisler HD; Rustum Y; Priore RL
    Eur J Cancer Clin Oncol; 1985 Jan; 21(1):23-30. PubMed ID: 4038655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.